Affinity Asset Advisors »

Generate Biomedicines Ord shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Generate Biomedicines Ord shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.4M 350k 12.50

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
FMR
Capital World Investors
Braidwell
Arch Venture Corp
HarbourVest Partners
Baker Bros. Advisors
Harvard Management Company
Nvidia Corp
Alyeska Investment Group
ARK Investment Management
Millennium Management
UBS Group
Affinity Asset Advisors
Morgan Stanley

View all funds holding Generate Biomedicines Ord